Docosahexaenoic acid is associated with endosteal circumference in long bones in young males with cystic fibrosis

In children, but not adults with cystic fibrosis (CF), associations between essential fatty acids (FA) and bone mass have been reported. Low bone mineral density (BMD) is common in these patients. Previously we found a normal annual increase of BMD, suggesting a potential for attaining normal bone mass. The aim of the present study was to investigate phospholipid FA pattern in relation to bone in young adult men with CF compared with healthy controls. Fourteen male patients with CF were compared with forty-two healthy controls, using dual-energy X-ray absorptiometry for total bone, lumbar spine and femur and peripheral quantitative computerised tomography for tibia and radius. A questionnaire concerning physical activity and nutrition was used. FA in serum phospholipids were measured using capillary GLC. CF patients did not differ in physical activity and anthropometry from controls. There were no differences in bone parameters between the two groups, but patients chronically colonised with Pseudomonas aeruginosa had lower BMD than non-colonised patients. The trabecular BMD in the tibia differed between patients and controls, but not after adjustment for age and weight. The endosteal circumference of the radius was significantly associated with serum phospholipid concentration of DHA and inversely with the n-6:n-3 FA ratio in CF patients but not in controls. The present study showed that young physically active adult males with classical CF obtained similar bone mass as controls, although influenced by pseudomonas colonisation. The association between DHA and long bone endosteal circumference suggested a later peak bone mass in those with CF compared with controls.

[1]  A. Nordström,et al.  n-3 Fatty acids are positively associated with peak bone mineral density and bone accrual in healthy men: the NO2 Study. , 2007, The American journal of clinical nutrition.

[2]  F. Sivas,et al.  The effect of outfitting style on bone mineral density , 2007, Rheumatology International.

[3]  A. Nordström,et al.  Relationship between Vitamin D Metabolites and Bone Mineral Density in Young Males: A Cross-Sectional and Longitudinal Study , 2006, Calcified Tissue International.

[4]  D. Mellström,et al.  Serum phospholipid fatty acid pattern is associated with bone mineral density in children, but not adults, with cystic fibrosis. , 2006, The British journal of nutrition.

[5]  D. Mellström,et al.  Pubertal Timing Predicts Previous Fractures and BMD in Young Adult Men: The GOOD Study , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  C. Colombo,et al.  BMD and Body Composition in Children and Young Patients Affected by Cystic Fibrosis , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  S. Shoff,et al.  Temporal Associations Among Energy Intake, Plasma Linoleic Acid, and Growth Improvement in Response to Treatment Initiation After Diagnosis of Cystic Fibrosis , 2006, Pediatrics.

[8]  H. Weiler,et al.  Maternal and Cord Blood Long-Chain Polyunsaturated Fatty Acids Are Predictive of Bone Mass at Birth in Healthy Term-Born Infants , 2005, Pediatric Research.

[9]  E. Manzato,et al.  Relationship between Plasma Phospholipid Polyunsaturated Fatty Acid Composition and Bone Disease in Renal Transplantation , 2005, Transplantation.

[10]  D. Mellström,et al.  Association of Amount of Physical Activity With Cortical Bone Size and Trabecular Volumetric BMD in Young Adult Men: The GOOD Study , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  D. Mellström,et al.  Free Testosterone Is a Positive, Whereas Free Estradiol Is a Negative, Predictor of Cortical Bone Size in Young Swedish Men: The GOOD Study , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  D. Mellström,et al.  Age of Attainment of Peak Bone Mass Is Site Specific in Swedish Men—The GOOD Study , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  P. Merkel,et al.  Consensus statement: Guide to bone health and disease in cystic fibrosis , 2005 .

[14]  B. Strandvik,et al.  Perinatal essential fatty acid deficiency influences body weight and bone parameters in adult male rats. , 2005, Biochimica et biophysica acta.

[15]  T. Kotsimbos,et al.  Reduced bone density in cystic fibrosis: ΔF508 mutation is an independent risk factor , 2005, European Respiratory Journal.

[16]  P. Merkel,et al.  Guide to bone health and disease in cystic fibrosis. , 2005, The Journal of clinical endocrinology and metabolism.

[17]  B. Strandvik,et al.  Dietary n-6:n-3 fatty acid ratio in the perinatal period affects bone parameters in adult female rats , 2004, British Journal of Nutrition.

[18]  C. Baudoin,et al.  Severe osteopenia in CFTR-null mice. , 2004, Bone.

[19]  D. Mellström,et al.  Normal annual increase of bone mineral density during two years in patients with cystic fibrosis. , 2004, Pediatrics.

[20]  L. Sharples,et al.  Inflammatory related changes in bone mineral content in adults with cystic fibrosis , 2004, Thorax.

[21]  S. Bell,et al.  Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study , 2004, Thorax.

[22]  B. Button,et al.  Physiotherapy in infants and young children with cystic fibrosis: current practice and future developments. , 2004, Journal of the Royal Society of Medicine.

[23]  P. Paré,et al.  Role of exercise and nutrition status on bone mineral density in cystic fibrosis. , 2003, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[24]  D. Mellström,et al.  Decreased bone mineral density in normal‐growing patients with cystic fibrosis , 2003, Acta paediatrica.

[25]  G. Brabant,et al.  Sex steroids and body composition in men with cystic fibrosis. , 2003, European journal of endocrinology.

[26]  O. Johnell,et al.  Physical Activity Increases Bone Size in Prepubertal Boys and Bone Mass in Prepubertal Girls: A Combined Cross-Sectional and 3-Year Longitudinal Study , 2002, Calcified Tissue International.

[27]  J. Adams,et al.  A prospective study of change in bone mineral density over one year in adults with cystic fibrosis , 2002, Thorax.

[28]  S. Conway Impact of lung inflammation on bone metabolism in adolescents with cystic fibrosis. , 2001, Paediatric respiratory reviews.

[29]  B. Strandvik,et al.  Essential fatty acid deficiency in relation to genotype in patients with cystic fibrosis. , 2001, The Journal of pediatrics.

[30]  K. Ellis,et al.  Normal bone mineral density in cystic fibrosis , 2001, Archives of disease in childhood.

[31]  M. F. Seifert,et al.  Bioactive fatty acids: role in bone biology and bone cell function. , 2001, Progress in lipid research.

[32]  B. Hollis,et al.  Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients. , 2001, The American journal of clinical nutrition.

[33]  L. Tsui,et al.  Spectrum of mutations in the CFTR gene of patients with classical and atypical forms of cystic fibrosis from southwestern Sweden: identification of 12 novel mutations. , 2001, Genetic testing.

[34]  H. White,et al.  Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors , 2000, Thorax.

[35]  M. Kosorok,et al.  Nutritional Status of Patients With Cystic Fibrosis With Meconium Ileus: A Comparison With Patients Without Meconium Ileus and Diagnosed Early Through Neonatal Screening , 2000, Pediatrics.

[36]  B. Strandvik,et al.  Natural history of liver disease in cystic fibrosis , 1999, Hepatology.

[37]  G. Gericke,et al.  Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis , 1998, Aging.

[38]  R. Marcus,et al.  Bone acquisition and loss in children and adults with cystic fibrosis: a longitudinal study. , 1998, The Journal of pediatrics.

[39]  J. Renner,et al.  Increased Rate of Fractures and Severe Kyphosis: Sequelae of Living into Adulthood with Cystic Fibrosis , 1998, Annals of Internal Medicine.

[40]  R. Frizzell,et al.  Cystic fibrosis gene mutation (deltaF508) is associated with an intrinsic abnormality in Ca2+-induced arachidonic acid release by epithelial cells. , 1997, DNA and cell biology.

[41]  G. Saggese,et al.  Bone Demineralization in Cystic Fibrosis: Evidence of Imbalance between Bone Formation and Degradation , 1997, Pediatric Research.

[42]  M. Kosorok,et al.  Effect of linoleic acid intake on growth of infants with cystic fibrosis. , 1996, The American journal of clinical nutrition.

[43]  D. Thiebaud,et al.  Bone mineral content in cystic fibrosis patients: correlation with fat-free mass. , 1996, Archives of disease in childhood.

[44]  R. Marcus,et al.  Correlates of osteopenia in patients with cystic fibrosis. , 1996, Pediatrics.

[45]  M. Gunnes,et al.  Dietary calcium, saturated fat, fiber and vitamin C as predictors of forearm cortical and trabecular bone mineral density in healthy children and adolescents , 1995, Acta paediatrica.

[46]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[47]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[48]  J. Lloyd-Still,et al.  Essential fatty acid status and fluidity of plasma phospholipids in cystic fibrosis infants. , 1991, The American journal of clinical nutrition.

[49]  B. Strandvik Antibiotic therapy of pulmonary infections in cystic fibrosis. Dosage schedules and duration of treatment. , 1988, Chest.

[50]  B. Strandvik,et al.  Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis , 1987, Journal of clinical microbiology.

[51]  B. Strandvik,et al.  Pathological regulation of arachidonic acid release in cystic fibrosis: the putative basic defect. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[52]  B. Strandvik,et al.  Physical activity and self treatment in cystic fibrosis. , 1986, Archives of disease in childhood.

[53]  J. Rivers,et al.  Essential fatty acid deficiency. , 1981, British medical bulletin.

[54]  L. Solymar,et al.  Nitrogen single breath test, flow-volume curves and spirometry in healthy children, 7-18 years of age. , 1980, European journal of respiratory diseases.